The Report on drug use in the Americas (CICAD, 2015), clearly documents emerging threats in CELAC. E.g., appearance in the illicit drug market of a number of new psychoactive substances (NPS); indications of initial consumption of heroin; increasing prevalence of drug use among adolescents, associated to very low perceived risk of the occasional use together with a very high perceived easy access to drugs. Those and other identified trends challenge policy-making, not only in DDR but also in DSR. Each WG will develop in-depth pilot information maps on a particular drug/threat in participating countries. Each WG will estimate indicators such as, prevalence in different population groups (general population, teens, inmates, university students, etc.; socio-demographic indicators associated with new trends; treatment indicators: available treatment centres, attendance, attrition rates and reasons, etc.). Potential subjects: heroin; cocaine base, crack (pasta base-cocainas fumables); marihuana; inhalable; new synthetic drugs.
22/08/17 - 23/08/17
Buenos Aires, Argentina
23/04/18 - 24/04/18
Buenos Aires, Argentina
Due to the characteristics of this Activity, its implementation is restricted —in its initial stages— to the CELAC countries that have already implemented one EWS, but the scope of the products to be developed will be addressed and will be useful to all interested countries. Within the notion of South-South cooperation, the support that this CELAC countries can offer each other will be favoured, counting on the support and input by experts from the EMCDDA-EU and OID-CICAD in the development of activities.
0.1 - Establish the necessary operational bases to ensure the quality and coherence of the work to be performed and the necessary coordination and participation of all partners.
0.2 - Have adequate baseline information to: provide specificity to the contents and the actions planned in each component; meet initial expectations of each partner in relation to its participation in COPOLAD; and facilitate the programme evaluation.
1.4 - Implement a sustainable bi-regional cooperation capacity building strategy focused on enhancing the reporting capacity of NDOs being in an early stage of development.
1.5 - Implement a cooperation capacity building strategy in key areas identified, with special focus on the assessment of rising trends of problematic use of specific drugs.
1.6 - Continue to develop training opportunities focused in building capacities for strategic planning and the use of monitoring methods and tools, which can be mutually complementary.
IIntermediate products: mapping report on new threats-problems; proposals for a methodological approach to the threats-problems
Implemented a sustainable capacity building strategy in key areas identified, with special focus on the assessment of rising trends of problematic use of specific drugs.
EU Reference country (WG)
Leader country (WG)
Leader country (WG)
This is a restricted section for participants who attended this activity. Ask for your username and password sending an email to info@copolad.eu
If you already have an username and password, you must log in at My COPOLAD and return to this activity to see the restricted sections.
This is a restricted section for participants who attended this activity. Ask for your username and password sending an email to info@copolad.eu
If you already have an username and password, you must log in at My COPOLAD and return to this activity to see the restricted sections.
This is a restricted section for participants who attended this activity. Ask for your username and password sending an email to info@copolad.eu
If you already have an username and password, you must log in at My COPOLAD and return to this activity to see the restricted sections.